Rudi Van den Eynde has been Head of Thematic Global Equity at Candriam since 2011, and manager of our flagship Biotechnology strategy for more than 24 years. In his role at Candriam and our predecessor companies since 1987, Rudi has accrued more than three decades of investment management experience in a variety of functions across multiple asset classes. His experience includes currency trading, and institutional client and private client management. He is a voting member of the Economic Outlook Committee at Candriam.
Discover the latest articles by Rudi Van den Eynde
Outlook 2024, Rudi Van den Eynde, Antoine Hamoir
Healthcare sector, though not in as good shape as the pandemic's end, exhibits resilience with promising indicators, when the economy may start coughing.
Malgorzata Kluba, Rudi Van den Eynde, Oncology, Equities
World Cancer Day 2023
And we would rather not have to go through this – which would mean we won the battle and cancer is curable.